BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2491400)

  • 1. [The value of individual laboratory tests in the evaluation of inflammatory activity in rheumatoid arthritis].
    Domljan Z; Sacer D
    Reumatizam; 1989; 36(1-6):31-4. PubMed ID: 2491400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The photometric latex test for rheumatoid factors in patients with rheumatoid arthritis. II. Clinical evaluation.
    Dezelić G; Dürrigl T; Dezelić N; Zergollern V; Jurak H; Vitaus M; Androić S
    Z Rheumatol; 1978; 37(3-4):112-22. PubMed ID: 636666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
    Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
    J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
    Mäkinen H; Kautiainen H; Hannonen P; Sokka T
    Ann Rheum Dis; 2005 Oct; 64(10):1410-3. PubMed ID: 15941836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
    Yazici Y; Pincus T; Kautiainen H; Sokka T
    J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis.
    Knijff-Dutmer EA; Koerts J; Nieuwland R; Kalsbeek-Batenburg EM; van de Laar MA
    Arthritis Rheum; 2002 Jun; 46(6):1498-503. PubMed ID: 12115179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease.
    Cimmino MA; Innocenti S; Livrone F; Magnaguagno F; Silvestri E; Garlaschi G
    Arthritis Rheum; 2003 May; 48(5):1207-13. PubMed ID: 12746893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
    Vlak T; Jajić Z
    Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased suppressive B cell factor (SBF) in rheumatoid arthritis: evidence for a defect in B cell autoregulation.
    White RE; Pisko EJ; Foster SL; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2151-7. PubMed ID: 3485142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of an antimalarial agent (chloroquine) on acute phase reactants in patients with rheumatoid arthritis].
    Jajić Z; Vuksic D; Jajić I
    Reumatizam; 1994; 41(2):5-7. PubMed ID: 8693197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.